Paperpal Prime Logo

Heterocyclic Communications : Impact Factor & More

eISSN: 2191-0197pISSN: 0793-0283
JournalOpen Access

Key Metrics

CiteScore
2.7
H-Index
26
Impact Factor
< 5
SJR
Q3Organic Chemistry
SNIP
0.66
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Heterocyclic Communications

Heterocyclic Communications Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
Publisher DE GRUYTER POLAND SP Z O O
Language English
Frequency Continuous publication
Article Processing ChargesEUR 1500
Publication Time15
Editorial Review ProcessAnonymous peer review
General Details
LanguageEnglish
FrequencyContinuous publication
Publication Start Year1994
Publisher URLVisit website
Website URLVisit website
Publication Details
PlagiarismVisit website
Publication Time 15
Waiver PolicyVisit website
Editorial Review Detail
Editorial TeamVisit website
Review ProcessAnonymous peer review
Review UrlVisit website
Information for authors
Author instructionsVisit website
Copyright DetailsVisit website
Deposit PolicySherpa/Romeo
License typeCC BY, CC BY-NC-ND
OA statementVisit website
View less

Planning to publish in Heterocyclic Communications ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Heterocyclic Communications

1,2,3-Triazole: an important scaffold in drug design and development
  • 23 Jan 2026
  • Heterocyclic Communications
Recent advancement of succinate dehydrogenase inhibitors based on the natural product scaffold
  • 23 Jan 2026
  • Heterocyclic Communications
Synthesis and antifungal activity of norbornene derivatives containing thiourea group
  • 23 Jan 2026
  • Heterocyclic Communications
Sustainable synthesis and comprehensive biological &amp; computational evaluation of pyrimidine derivatives
  • 23 Jan 2026
  • Heterocyclic Communications
1,2,3-Triazole: an important scaffold in drug design and development
  • 23 Jan 2026
  • Heterocyclic Communications
Recent advancement of succinate dehydrogenase inhibitors based on the natural product scaffold
  • 23 Jan 2026
  • Heterocyclic Communications
Synthesis and antifungal activity of norbornene derivatives containing thiourea group
  • 23 Jan 2026
  • Heterocyclic Communications
Sustainable synthesis and comprehensive biological &amp; computational evaluation of pyrimidine derivatives
  • 23 Jan 2026
  • Heterocyclic Communications

FAQs on Heterocyclic Communications